Capital Advisors Inc Bristol Myers Squibb CO Transaction History

Capital Advisors Inc

  • $4.86 Billion
  • Q3 2024

A detailed history of Capital Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Advisors Inc holds 12,703 shares of BMY stock, worth $732,327. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,703
Previous 13,916 8.72%
Holding current value
$732,327
Previous $577,000 13.86%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024
SELL
$39.66 - $51.75 $48,107 - $62,772
-1,213 Reduced 8.72%
12,703 $657,000
Q2 2024

Jul 31, 2024
BUY
$40.25 - $52.99 $46,529 - $61,256
1,156 Added 9.06%
13,916 $577,000
Q1 2024

Apr 29, 2024
BUY
$47.98 - $54.4 $1,055 - $1,196
22 Added 0.17%
12,760 $691,000
Q4 2023

Jan 29, 2024
SELL
$48.48 - $57.85 $7,029 - $8,388
-145 Reduced 1.13%
12,738 $653,000
Q3 2023

Oct 24, 2023
SELL
$57.89 - $64.73 $113,811 - $127,259
-1,966 Reduced 13.24%
12,883 $747,000
Q2 2023

Jul 18, 2023
BUY
$63.71 - $70.74 $53,261 - $59,138
836 Added 5.97%
14,849 $949,000
Q1 2023

Apr 19, 2023
SELL
$65.71 - $74.53 $27,203 - $30,855
-414 Reduced 2.87%
14,013 $971,000
Q4 2022

Jan 17, 2023
SELL
$68.48 - $81.09 $57,797 - $68,439
-844 Reduced 5.53%
14,427 $0
Q3 2022

Oct 17, 2022
BUY
$0.13 - $76.84 $193 - $114,107
1,485 Added 10.77%
15,271 $1.09 Million
Q2 2022

Jul 15, 2022
SELL
$72.62 - $79.98 $8,278 - $9,117
-114 Reduced 0.82%
13,786 $1.06 Million
Q1 2022

May 05, 2022
SELL
$61.48 - $73.72 $74,636 - $89,496
-1,214 Reduced 8.03%
13,900 $1.02 Million
Q4 2021

Jan 27, 2022
SELL
$53.63 - $62.52 $15.9 Million - $18.5 Million
-295,657 Reduced 95.14%
15,114 $942,000
Q3 2021

Oct 25, 2021
BUY
$59.17 - $69.31 $194,136 - $227,406
3,281 Added 1.07%
310,771 $18.4 Million
Q2 2021

Aug 02, 2021
BUY
$61.91 - $67.42 $1.53 Million - $1.66 Million
24,634 Added 8.71%
307,490 $20.5 Million
Q1 2021

May 25, 2021
BUY
$59.34 - $66.74 $1.22 Million - $1.37 Million
20,526 Added 7.82%
282,856 $17.9 Million
Q4 2020

Feb 08, 2021
BUY
$57.74 - $65.43 $1.95 Million - $2.21 Million
33,721 Added 14.75%
262,330 $16.3 Million
Q3 2020

Nov 02, 2020
BUY
$57.43 - $63.64 $649,648 - $719,895
11,312 Added 5.21%
228,609 $13.8 Million
Q2 2020

Aug 07, 2020
BUY
$54.82 - $64.09 $10.8 Million - $12.6 Million
196,686 Added 954.28%
217,297 $13.3 Million
Q1 2020

May 21, 2020
SELL
$46.4 - $67.43 $41,992 - $61,024
-905 Reduced 4.21%
20,611 $1.15 Million
Q4 2019

Feb 04, 2020
BUY
$49.21 - $64.19 $62,299 - $81,264
1,266 Added 6.25%
21,516 $1.38 Million
Q2 2019

Aug 07, 2019
BUY
$44.62 - $49.34 $481,583 - $532,526
10,793 Added 114.13%
20,250 $0
Q1 2019

May 10, 2019
SELL
$45.12 - $53.8 $561,879 - $669,971
-12,453 Reduced 56.84%
9,457 $0
Q4 2018

Feb 06, 2019
BUY
$48.76 - $63.23 $35,984 - $46,663
738 Added 3.49%
21,910 $1.14 Million
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $3,642 - $4,108
-66 Reduced 0.31%
21,172 $1.31 Million
Q2 2018

Aug 06, 2018
SELL
$50.53 - $62.98 $7.12 Million - $8.87 Million
-140,838 Reduced 86.9%
21,238 $0
Q1 2018

May 04, 2018
BUY
$59.92 - $68.98 $387,442 - $446,024
6,466 Added 4.16%
162,076 $0
Q4 2017

Jan 29, 2018
SELL
$59.94 - $65.35 $70,729 - $77,113
-1,180 Reduced 0.75%
155,610 $9.54 Million
Q3 2017

Nov 14, 2017
SELL
$55.23 - $63.74 $225,283 - $259,995
-4,079 Reduced 2.54%
156,790 $9.99 Million
Q2 2017

Aug 09, 2017
BUY
N/A
160,869
160,869 $8.96 Million

Others Institutions Holding BMY

# of Institutions
2,537
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital Advisors Inc Portfolio

Follow Capital Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email